Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Annales De Biologie Clinique
|
January 1, 1989
[Apropos of the monitoring of treatment with low molecular weight heparins]
F Toulemonde, B Bayrou
Annales De Chirurgie
|
November 1, 1977
[Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin]
A Kher, F Toulemonde
Annales De Cardiologie Et D'Angeiologie
|
March 1, 1995
[Monitoring of heparin in the treatment of deep venous thrombosis. An obsolete question?]
F Toulemonde, A Kher
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
Is pulmonary embolism a suitable evaluation criterion of the efficacy of prophylactic treatment in surgery
F Toulemonde, C Doutremepuich
Anesthesie, Analgesie, Reanimation
|
May 1, 1975
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings]
F Toulemonde, A Kher
Annales De Chirurgie
|
February 1, 1975
[Incidence and severity of postoperative thromboembolic accidents. Assessment of the prophylactic use of low dosage heparin (author's transl)]
A Kher, F Toulemonde
La Nouvelle Presse Medicale
|
April 10, 1976
[Treatment of deep venous thromboses using a plasminogen-streptokinase sequence. Preliminary study]
V V Kakkar, F Toulemonde
La Nouvelle Presse Medicale
|
June 9, 1973
[Long term heparinotherapy and osteoporosis]
A Kher, F Toulemonde, C Raby
Presse Medicale (Paris, France : 1983)
|
January 2, 1993
[Difficulties of assessing postoperative pulmonary embolisms. Risks of meta-analysis from clinical trials]
F Toulemonde, A Kher, C Doutremepuich
Thrombosis Research
|
December 1, 1986
Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractions
C Doutremepuich, F Bousquet, F Toulemonde
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Annales De Biologie Clinique
|
January 1, 1989
[Apropos of the monitoring of treatment with low molecular weight heparins]
F Toulemonde, B Bayrou
Annales De Chirurgie
|
November 1, 1977
[Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin]
A Kher, F Toulemonde
Annales De Cardiologie Et D'Angeiologie
|
March 1, 1995
[Monitoring of heparin in the treatment of deep venous thrombosis. An obsolete question?]
F Toulemonde, A Kher
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
Is pulmonary embolism a suitable evaluation criterion of the efficacy of prophylactic treatment in surgery
F Toulemonde, C Doutremepuich
Anesthesie, Analgesie, Reanimation
|
May 1, 1975
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings]
F Toulemonde, A Kher
Annales De Chirurgie
|
February 1, 1975
[Incidence and severity of postoperative thromboembolic accidents. Assessment of the prophylactic use of low dosage heparin (author's transl)]
A Kher, F Toulemonde
La Nouvelle Presse Medicale
|
April 10, 1976
[Treatment of deep venous thromboses using a plasminogen-streptokinase sequence. Preliminary study]
V V Kakkar, F Toulemonde
La Nouvelle Presse Medicale
|
June 9, 1973
[Long term heparinotherapy and osteoporosis]
A Kher, F Toulemonde, C Raby
Presse Medicale (Paris, France : 1983)
|
January 2, 1993
[Difficulties of assessing postoperative pulmonary embolisms. Risks of meta-analysis from clinical trials]
F Toulemonde, A Kher, C Doutremepuich
Thrombosis Research
|
December 1, 1986
Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractions
C Doutremepuich, F Bousquet, F Toulemonde
Page
of 7